Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation
NCT00946179
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
130
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Influenza virus (split virion, inactivated) vaccine
Sponsor
Sanofi Pasteur, a Sanofi Company